Taro Pharmaceutical Industries (TARO) Earning Positive Press Coverage, Analysis Finds

Media headlines about Taro Pharmaceutical Industries (NYSE:TARO) have trended positive on Thursday, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Taro Pharmaceutical Industries earned a news impact score of 0.28 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.3599924814803 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Taro Pharmaceutical Industries (NYSE TARO) traded up $0.34 during trading on Thursday, hitting $104.51. 81,400 shares of the stock traded hands, compared to its average volume of 174,745. The company has a market capitalization of $4,190.00, a PE ratio of 12.89 and a beta of 0.62. Taro Pharmaceutical Industries has a twelve month low of $94.00 and a twelve month high of $128.46.

Separately, BidaskClub upgraded shares of Taro Pharmaceutical Industries from a “hold” rating to a “buy” rating in a report on Thursday, September 28th.

TRADEMARK VIOLATION NOTICE: “Taro Pharmaceutical Industries (TARO) Earning Positive Press Coverage, Analysis Finds” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/05/taro-pharmaceutical-industries-taro-earning-positive-press-coverage-analysis-finds.html.

Taro Pharmaceutical Industries Company Profile

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Insider Buying and Selling by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply